EPCAM and prostate carcinoma: In a sixth study, using near‐infrared dyes and EpCAM immunostaining, up to 439 CTCs per mL of blood (mean: 25 CTCs/mL; median: 10 CTCs/mL) were observed in a cohort of patients with localized prostate cancer.18